RENALIN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2003-06-02 for RENALIN manufactured by Minntech Corporation.

Event Text Entries

[20891963] 4 patients experienced reactions on initiation of dialysis. Symptoms included numbness of the lips, swelling of the jaw, hypotension, shortness of breath, diarrhea and back pain. 1 patient was removed from dialysis and sent to the hospital. 3 remaining patients were taken off of dialysis and sent home. Patient sent to the hospital er was treated and released. This patient did not require hospitalization. All 4 patients doing well with no ill effects reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2150060-2003-00007
MDR Report Key463917
Report Source05,06
Date Received2003-06-02
Date of Report2003-05-30
Date of Event2003-05-05
Date Facility Aware2003-05-05
Report Date2003-05-30
Date Mfgr Received2003-05-05
Date Added to Maude2003-06-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer Street14605 28TH AVENUE, NORTH
Manufacturer CityMINNEAPOLIS MN 55447
Manufacturer CountryUS
Manufacturer Postal55447
Manufacturer Phone7635533300
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameRENALIN
Generic NameCOLD STERILANT
Product CodeLIF
Date Received2003-06-02
Model NumberNA
Catalog NumberNA
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeUNKNOWN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key452861
ManufacturerMINNTECH CORPORATION
Manufacturer Address14605 28TH AVE. NORTH MINNEAPOLIS MN 55447 US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other; 3. Required No Informationntervention 2003-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.